A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.
Condition: Non-Small Cell Lung Cancer Interventions: Drug: lorlatinib; Drug: crizotinib; Drug: brigatinib; Drug: ceritinib; Drug: alectinib; Drug: atezolizumab; Drug: bevacizumab; Drug: paclitaxel; Drug: carboplatin; Drug: docetaxel; Drug: erlotinib; Drug: gefitinib; Drug: afatinib; Drug: dacomi tinib; Drug: osimertinib; Drug: pembrolizumab; Drug: nivolumab; Drug: entrectinib Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer | Cancer & Oncology | Docetaxel | Learning | Lung Cancer | Non-Small Cell Lung Cancer | Norway Health | Pfizer | Research | Study | Tarceva | Taxotere | Universities & Medical Training